Cited by 565Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsInflammasome and immune disorders

The DOI matches its Crossref record; 157 of the 158 references it cites were found in a registry or an index.

The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective

Open access

Shaftel, Solomon S, Griffin, W Sue T, O'Banion, M Kerry·2008·Journal of Neuroinflammation

DOI 10.1186/1742-2094-5-7PMC PMC2335091

Open this paper in CoChat — free account Open PDF

Abstract

Elevation of the proinflammatory cytokine Interleukin-1 (IL-1) is an integral part of the local tissue reaction to central nervous system (CNS) insult. The discovery of increased IL-1 levels in patients following acute injury and in chronic neurodegenerative disease laid the foundation for two decades of research that has provided important details regarding IL-1's biology and function in the CNS. IL-1 elevation is now recognized as a critical component of the brain's patterned response to insults, termed neuroinflammation, and of leukocyte recruitment to the CNS. These processes are believed to underlie IL-1's function in the setting of acute brain injury, where it has been ascribed potential roles in repair as well as in exacerbation of damage. Explorations of IL-1's role in chronic neurodegenerative disease have mainly focused on Alzheimer disease (AD), where indirect evidence has implicated it in disease pathogenesis. However, recent observations in animal models challenge earlier assumptions that IL-1 elevation and resulting neuroinflammatory processes play a purely detrimental role in AD, and prompt a need for new characterizations of IL-1 function. Potentially adaptive functions of IL-1 elevation in AD warrant further mechanistic studies, and provide evidence that enhancement of these effects may help to alleviate the pathologic burden of disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1186/1742-2094-5-7

Cites

157 of 157 references verified0 citation errors · 0 not checkable

Statistics

Figure 1 A schematic depiction of potential roles of IL-1 in AD.CC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

American Journal of Pathology
(2015) · American Journal Of Pathology · doi:10.2353/ajpath · Cited by 4,961
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Neutrophils and immunity: challenges and opportunities
Nathan, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1785 · Cited by 2,971
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Self-citation
Immunoregulatory Feedback Between Interleukin-1 and Glucocorticoid Hormones
Besedovsky, H., del Rey, A., Sorkin, E., & Dinarello, C. A. (1986) · Science · doi:10.1126/science.3014662 · Cited by 1,519
Untitled work
Wyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284
MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1
Malinin, N. L., Boldin, M., Kovalenko, A. V., & Wallach, D. (1997) · Nature · doi:10.1038/385540a0 · Cited by 1,279
Bone Marrow-Derived Microglia Play a Critical Role in Restricting Senile Plaque Formation in Alzheimer's Disease
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
in 't Veld, B. A., Ruitenberg, A., Hofman, A., Launer, L. J., van Duijn, C. M., Stijnen, T., Breteler, M. M. B., & Stricker, B. H. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010178 · Cited by 1,196
IRAK (Pelle) Family Member IRAK-2 and MyD88 as Proximal Mediators of IL-1 Signaling
Muzio, M., Ni, J., Feng, P., & Dixit, V. M. (1997) · Science · doi:10.1126/science.278.5343.1612 · Cited by 1,170
Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1
Berkenbosch, F., van Oers, J., del Rey, A., Tilders, F., & Besedovsky, H. (1987) · Science · doi:10.1126/science.2443979 · Cited by 1,151
Risk of Alzheimer's disease and duration of NSAID use
Stewart, W. F., Kawas, C., Corrada, M., & Metter, E. J. (1997) · Neurology · doi:10.1212/wnl.48.3.626 · Cited by 1,132
Three or more routes for leukocyte migration into the central nervous system
Ransohoff, R. M., Kivisäkk, P., & Kidd, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1130 · Cited by 1,052
Interleukin-1 and neuronal injury
Allan, S. M., Tyrrell, P. J., & Rothwell, N. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1664 · Cited by 992
Clinical trial of indomethacin in Alzheimer's disease
Rogers, J., Kirby, L., Hempelman, S. R., Berry, D. A., McGeer, P. L., Kaszniak, A. W., Zalinski, J., Cofield, M., Mansukhani, L., Willson, P., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1609 · Cited by 991
Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease
Lim, G. P., Yang, F., Chu, T., Chen, P., Beech, W. K., Teter, B., Tran, T., Ubeda, O. J., Ashe, K. H., Frautschy, S. A., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05709.2000 · Cited by 876
CNS immune privilege: hiding in plain sight
Carson, M. J., Doose, J. M., Melchior, B., Schmid, C. D., & Ploix, C. C. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00441.x · Cited by 838
Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR
McGeer, P. L., Itagaki, S., Tago, H., & McGeer, E. G. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90696-3 · Cited by 836
Inflammatory processes in Alzheimer's disease
Heneka, M. T., & O'Banion, M. K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.017 · Cited by 782
Self-citation
Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease
Rogers, J., Luber-Narod, J., Styren, S. D., & Civin, W. H. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80079-4 · Cited by 743
The role of inflammation in Alzheimer’s disease
Tuppo, E. E., & Arias, H. R. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.07.009 · Cited by 734
Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression
Griffin, W. S. T., Sheng, J. G., Royston, M. C., Gentleman, S., McKenzie, J. E., Graham, D. I., Roberts, G. W., & Mrak, R. E. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00136.x · Cited by 712
Self-citation
Inflammatory response in acute traumatic brain injury: a double-edged sword
Morganti-Kossmann, M., Rancan, M., Stahel, P., & Kossmann, T. (2002) · Current Opinion in Critical Care · doi:10.1097/00075198-200204000-00002 · Cited by 702
Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease
Kitazawa, M., Oddo, S., Yamasaki, T. R., Green, K. N., & LaFerla, F. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2868-05.2005 · Cited by 697
Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E
Barger, S. W., & Harmon, A. D. (1997) · Nature · doi:10.1038/42257 · Cited by 622
Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery
Kennedy, M., Torrance, D., Picha, K. S., & Mohler, K. M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.7.2496 · Cited by 618
Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells.
Goldgaber, D., Harris, H. W., Hla, T., Maciag, T., DONNELLY, R. J., Jacobsen, J. S., Vitek, M. P., & Gajdusek, D. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7606 · Cited by 597
Microglial response to amyloid plaques in APPsw transgenic mice.
Frautschy, S. A., Yang, F., Irrizarry, M., Hyman, B. T., Saido, T. C., Hsiao, K., & Cole, G. M. (1998) · Europe PMC (PubMed Central) · Cited by 592
Glia and their cytokines in progression of neurodegeneration
Mrak, R. E., & Griffin, W. S. T. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.05.010 · Cited by 592
Self-citation
TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice
Wyss-Coray, T., Lin, C., Yan, F., Yu, G.-Q., Rohde, M., McConlogue, L., Masliah, E., & Mucke, L. (2001) · Nature Medicine · doi:10.1038/87945 · Cited by 587
Inverse association of anti‐inflammatory treatments and Alzheimer's disease
Breitner, J. C. S., Gau, B. A., Welsh-Bohmer, K. A., Plassman, B. L., McDonald, W. M., Helms, M. J., & Anthony, J. C. (1994) · Neurology · doi:10.1212/wnl.44.2.227 · Cited by 569
Interleukin-1 Mediates Pathological Effects of Microglia on Tau Phosphorylation and on Synaptophysin Synthesis in Cortical Neurons through a p38-MAPK Pathway
Li, Y., Liu, L., Barger, S. W., & Griffin, W. S. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01605.2003 · Cited by 563
Self-citation
Interleukin-1 Expression in Different Plaque Types in Alzheimerʼs Disease
Griffin, W. S. T., Sheng, J. G., Roberts, G. W., & Mrak, R. E. (1995) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199503000-00014 · Cited by 546
Self-citation
Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease
Mogi, M., Harada, M., Narabayashi, H., Inagaki, H., Minami, M., & Nagatsu, T. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12706-3 · Cited by 545
Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke.
Connolly, E. S., Winfree, C. J., Springer, T. A., Naka, Y., Liao, H., Yan, S., Stern, D., Solomon, R. A., Gutierrez‐Ramos, J. C., & Pinsky, D. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118392 · Cited by 523
Role of IL-1α and IL-1β in Ischemic Brain Damage
Boutin, H., Feuvre, R. A. L., Horai, R., Asano, M., Iwakura, Y., & Rothwell, N. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05528.2001 · Cited by 521
Interleukin-1β Promotes Repair of the CNS
Mason, J. L., Suzuki, K., Chaplin, D. D., & Matsushima, G. K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07046.2001 · Cited by 502
A neuromodulatory role of interleukin-1β in the hippocampus
Schneider, H., Pitossi, F., Balschun, D., Wagner, A., del Rey, A., & Besedovsky, H. O. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7778 · Cited by 498
NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies
McGeer, P. L., & McGeer, E. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.013 · Cited by 498
Visualization and characterization of interleukin 1 receptors in brain.
Farrar, W. L., Kilian, P. L., Ruff, M. R., Hill, J. M., & Pert, C. B. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.2.459 · Cited by 458
Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy
Bacskai, B. J., Kajdasz, S. T., Christie, R. H., Carter, C., Games, D., Seubert, P. A., Schenk, D., & Hyman, B. T. (2001) · Nature Medicine · doi:10.1038/85525 · Cited by 445
A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients
Emsley, H. C. A. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.054882 · Cited by 444
Sustained hippocampal IL-1β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology
Shaftel, S. S., Kyrkanides, S., Olschowka, J. A., Miller, J.-N. H., Johnson, R. E., & O’Banion, M. K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31450 · Cited by 433
Self-citation
Interleukin-1β Causes Pulmonary Inflammation, Emphysema, and Airway Remodeling in the Adult Murine Lung
Lappalainen, U., Whitsett, J. A., Wert, S. E., Tichelaar, J. W., & Bry, K. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0309oc · Cited by 430
Interleukin‐1β contributes to the generation of experimental febrile seizures
Dubé, C. M., Vezzani, A., Behrens, M., Bartfai, T., & Baram, T. Z. (2004) · Annals of Neurology · doi:10.1002/ana.20358 · Cited by 423
Phenotypic and functional characterization of mice that lack the type I receptor for IL-1.
Glaccum, M. B., Stocking, K., Charrier, K., Smith, J., Willis, C., Maliszewski, C., Livingston, D., Peschon, J., & Morrissey, P. (1997) · Journal of Immunology · doi:10.4049/jimmunol.159.7.3364 · Cited by 418
Nonsteroidal Anti-Inflammatory Drugs for the Prevention of Alzheimer’s Disease: A Systematic Review
Szekely, C. A., Thorne, J. E., Zandi, P. P., Ek, M., Messias, E., Breitner, J. C. S., & Goodman, S. N. (2004) · Neuroepidemiology · doi:10.1159/000078501 · Cited by 402
Impaired interleukin‐1 signaling is associated with deficits in hippocampal memory processes and neural plasticity
Avital, A., Goshen, I., Kamsler, A., Segal, M., Iverfeldt, K., Richter‐Levin, G., & Yirmiya, R. (2003) · Hippocampus · doi:10.1002/hipo.10135 · Cited by 396
Tumor Necrosis Factor-α, Interleukin-1β, and Interferon-γ Stimulate γ-Secretase-mediated Cleavage of Amyloid Precursor Protein through a JNK-dependent MAPK Pathway
Liao, Y.-F., Wang, B.-J., Cheng, H.-T., Kuo, L.-H., & Wolfe, M. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402034200 · Cited by 389
Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid β peptide in APPswe transgenic mice
Sheng, J. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00069-x · Cited by 388
A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer’s disease
Scharf, S., Mander, A. G., Ugoni, A., Vajda, F. J. E., & Christophidis, N. (1999) · Neurology · doi:10.1212/wnl.53.1.197 · Cited by 385
Rofecoxib
Reines, S. A., Block, G. A., Morris, J. C., Liu, G., Nessly, M. L., Lines, C. R., Norman, B., & Baranak, C. C. (2004) · Neurology · doi:10.1212/wnl.62.1.66 · Cited by 384
Interleukin‐1: A master regulator of neuroinflammation
Basu, A., Krady, J. K., & Levison, S. W. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20266 · Cited by 380
Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial
ADAPT Research Group (2007) · Neurology · doi:10.1212/01.wnl.0000260269.93245.d2 · Cited by 354
Cytokine activation of the HPA axis
DUNN, A. J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05426.x · Cited by 352
Chemokine binding and activities mediated by the mouse IL-8 receptor
Lee, J., Cacalano, G., Camerato, T. R., Toy, K. J., Moore, M. W., & Wood, W. I. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.4.2158 · Cited by 348
Microglial Activation and β-Amyloid Deposit Reduction Caused by a Nitric Oxide-Releasing Nonsteroidal Anti-Inflammatory Drug in Amyloid Precursor Protein Plus Presenilin-1 Transgenic Mice
Jantzen, P. T., Connor, K. E., DiCarlo, G., Wenk, G. L., Wallace, J. L., Rojiani, A. M., Coppola, D., Morgan, D., & Gordon, M. N. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02246.2002 · Cited by 341
Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways.
Carlson, N. G., Wieggel, W. A., Chen, J., Bacchi, A., Rogers, S. W., & Gahring, L. C. (1999) · PubMed · Cited by 336
In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse
Cunningham, E. T., Wada, E., Carter, D., Tracey, D. E., Battey, J., & Souza, E. B. D. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-03-01101.1992 · Cited by 331
The immune system and memory consolidation: a role for the cytokine IL-1β
Pugh, C., Fleshner, M., Watkins, L. R., Maier, S. F., & Rudy, J. W. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00048-8 · Cited by 317
Evidence for glial-mediated inflammation in aged APPSW transgenic mice
Benzing, W. C., Wujek, J. R., Ward, E. K., Shaffer, D. J., Ashe, K. H., Younkin, S. G., & Brunden, K. R. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00065-2 · Cited by 303
Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer’s disease
Matsuoka, Y., Picciano, M., Malester, B., LaFrancois, J., Zehr, C., Daeschner, J. M., Olschowka, J. A., Fonseca, M. I., O’Banion, M. K., Tenner, A. J., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64085-0 · Cited by 303
Self-citation
Inflammatory Cytokines IL-1α, IL-1β, IL-6, and TNF-α Impart Neuroprotection to an Excitotoxin Through Distinct Pathways
Carlson, N. G., Wieggel, W. A., Chen, J., Bacchi, A., Rogers, S. W., & Gahring, L. C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3963 · Cited by 301
Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to β-amyloid deposition in APP/PS1 double transgenic Alzheimer mice
Malm, T. M., Koistinaho, M., Pärepalo, M., Vatanen, T., Ooka, A., Karlsson, S., & Koistinaho, J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.009 · Cited by 301
Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential
Rothwell, N. J. (2003) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(02)00098-3 · Cited by 291
Translation of the Alzheimer Amyloid Precursor Protein mRNA Is Up-regulated by Interleukin-1 through 5′-Untranslated Region Sequences
Rogers, J. T., Leiter, L. M., McPhee, J., Cahill, C. M., Zhan, S.-S., Potter, H., & Nilsson, L. N. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6421 · Cited by 290
Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism
Chao, C. C., Hu, S., Sheng, W. S., Bu, D.-F., Bukrinsky, M., & Peterson, P. K. (1996) · Glia · doi:10.1002/(sici)1098-1136(199603)16:3 · Cited by 273
In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis
Sheng, J. G., Ito, K., Skinner, R. D., Mrak, R. E., Rovnaghi, C. R., van Eldik, L. J., & Griffin, W. S. T. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00104-2 · Cited by 269
Self-citation
Interleukin-1 mediates Alzheimer and Lewy body pathologies
Griffin, W. S. T., Liu, L., Li, Y., Mrak, R. E., & Barger, S. W. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-5 · Cited by 267
Self-citation
Cytokine accumulations in CSF of multiple sclerosis patients
Hauser, S. L., Doolittle, T. H., Lincoln, R., Brown, R. H., & Dinarello, C. A. (1990) · Neurology · doi:10.1212/wnl.40.11.1735 · Cited by 264
Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice
Janelsins, M. C., Mastrangelo, M. A., Oddo, S., LaFerla, F. M., Federoff, H. J., & Bowers, W. J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-23 · Cited by 260
Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats
Anthony, D. C. (1997) · Brain · doi:10.1093/brain/120.3.435 · Cited by 252
Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat
Toulmond, S., & Rothwell, N. J. (1995) · Brain Research · doi:10.1016/0006-8993(94)01343-g · Cited by 248
Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion.
García, J. H., Liu, K. F., & Relton, J. K. (1995) · PubMed · Cited by 244
Chronic Interleukin-1β Expression in Mouse Brain Leads to Leukocyte Infiltration and Neutrophil-Independent Blood–Brain Barrier Permeability without Overt Neurodegeneration
Shaftel, S. S., Carlson, T. J., Olschowka, J. A., Kyrkanides, S., Matousek, S. B., & O'Banion, M. K. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1418-07.2007 · Cited by 243
Self-citation
Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1β in the substantia nigra
Ferrari, C. C., Pott Godoy, M. C., Tarelli, R., Chertoff, M., Depino, A. M., & Pitossi, F. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.013 · Cited by 235
Chemokine networks in vivo: involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-alpha
Tessier, P. A., Naccache, P. H., Clark‐Lewis, I., Gladue, R. P., Neote, K. S., & McColl, S. R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3595 · Cited by 233
CXC Chemokine Receptor-2 Ligands Are Necessary Components of Neutrophil-Mediated Host Defense in Invasive Pulmonary Aspergillosis
Mehrad, B., Strieter, R. M., Moore, T. A., Tsai, W. C., Lira, S. A., & Standiford, T. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6086 · Cited by 232
Deletion of the Prostaglandin E2EP2 Receptor Reduces Oxidative Damage and Amyloid Burden in a Model of Alzheimer's Disease
Liang, X., Wang, Q., Hand, T. A., Wu, L., BREYER, R. M., Montine, T. J., & Andreasson, K. I. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3591-05.2005 · Cited by 232
Lipopolysaccharide-induced microglial activation induces learning and memory deficits without neuronal cell deathin rats
Tanaka, S., Ide, M., Shibutani, T., Ohtaki, H., Numazawa, S., Shioda, S., & Yoshida, T. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20752 · Cited by 224
Minocycline affects microglia activation, Aβ deposition, and behavior in APP‐tg mice
Seabrook, T. J., Jiang, L., Maier, M., & Lemere, C. A. (2006) · Glia · doi:10.1002/glia.20338 · Cited by 223
Intrahippocampal LPS injections reduce AÎ² load in APP+PS1 transgenic mice
DiCarlo, G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00292-5 · Cited by 223
Interleukin-1 Regulates Proliferation and Differentiation of Oligodendrocyte Progenitor Cells
Vela, J. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1127 · Cited by 223
Inflammation, anti-inflammatory agents and Alzheimer disease: The last 12 years
McGeer, P. L., Rogers, J., & McGeer, E. G. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s330 · Cited by 222
CXCR2 Deficiency Confers Impaired Neutrophil Recruitment and Increased Susceptibility During Toxoplasma gondii Infection
Rı́o, L. D., Bennouna, S., Salinas, J., & Denkers, E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6503 · Cited by 217
Glial-Neuronal Interactions in Alzheimer Disease
Sheng, J. G., Mrak, R. E., & Griffin, W. S. T. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199703000-00007 · Cited by 215
Self-citation
The microglial phagocytic role with specific plaque types in the Alzheimer disease brain
D’Andrea, M. R., Cole, G. M., & Ard, M. D. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.026 · Cited by 215
Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor
Strijbos, P. J. L. M., & Rothwell, N. J. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-05-03468.1995 · Cited by 214
CXC Chemokine Receptor-2 Ligands Are Required for Neutrophil-Mediated Host Defense in Experimental Brain Abscesses
Kielian, T., Barry, B. J., & Hickey, W. F. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4634 · Cited by 208
Reversible Demyelination, Blood-Brain Barrier Breakdown, and Pronounced Neutrophil Recruitment Induced by Chronic IL-1 Expression in the Brain
Ferrari, C. C., Depino, A. M., Prada, F., Muraro, N. I., Campbell, S. J., Podhajcer, O. L., Perry, V. H., Anthony, D. C., & Pitossi, F. J. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63438-4 · Cited by 204
Microglial activation facilitates Aβ plaque removal following intracranial anti-Aβ antibody administration
Wilcock, D. M., Munireddy, S. K., Rosenthal, A., Ugen, K. E., Gordon, M. N., & Morgan, D. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.015 · Cited by 202
Increased Neuronal β‐Amyloid Precursor Protein Expression in Human Temporal Lobe Epilepsy: Association with Interleukin‐1α Immunoreactivity
Sheng, J. G., Boop, F. A., Mrak, R. E., & Griffin, W. S. T. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63051872.x · Cited by 201
Self-citation
Polymorphisms in Inflammatory Genes and the Risk of Alzheimer Disease
McGeer, P. L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.11.1790 · Cited by 194
Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain.
Brugg, B., Lemaigre‐Dubreuil, Y., Huber, G., Wollman, E. E., Delhaye‐Bouchaud, N., & Mariani, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.3032 · Cited by 191
Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms
Sheng, J. G., Mrak, R. E., & Griffin, W. S. T. (1997) · Acta Neuropathologica · doi:10.1007/s004010050664 · Cited by 191
Self-citation
Interleukin‐1β Induces Prostaglandin G/H Synthase‐2 (Cyclooxygenase‐2) in Primary Murine Astrocyte Cultures
O’Banion, M. K., Miller, J. C., Chang, J. W., Kaplan, M. D., & Coleman, P. D. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062532.x · Cited by 185
Self-citation
Randomized pilot study of nimesulide treatment in Alzheimer’s disease
Aisen, P. S. S., Schmeidler, J., & Pasinetti, G. M. (2002) · Neurology · doi:10.1212/wnl.58.7.1050 · Cited by 179
OVERRIDING THE BRAIN'S INTRINSIC RESISTANCE TO LEUKOCYTE RECRUITMENT WITH INTRAPARENCHYMAL INJECTIONS OF RECOMBINANT CHEMOKINES
Bell, M. D., Taub, D. D., & Perry, V. H. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00083-8 · Cited by 178
The Role of Leukocytes Following Cerebral Ischemia: Pathogenic Variable or Bystander Reaction to Emerging Infarct?
Emerich, D. F., Dean, R. L., & Bartus, R. T. (2002) · Experimental Neurology · doi:10.1006/exnr.2001.7835 · Cited by 174
Microglial interleukin-lα expression in human head injury: Correlations with neuronal and neuritic β-amyloid precursor protein expression
Griffin, W. S. T., Sheng, J. G., Gentleman, S. M., Graham, D. I., Mrak, R. E., & Roberts, G. W. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90066-3 · Cited by 171
Self-citation
The Type 1 Interleukin-1 Receptor Is Essential for the Efficient Activation of Microglia and the Induction of Multiple Proinflammatory Mediators in Response to Brain Injury
Basu, A., Krady, J. K., O’Malley, M. E., Styren, S. D., DeKosky, S. T., & Levison, S. W. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-14-06071.2002 · Cited by 170
Selective ablation of bone marrow‐derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model
Butovsky, O., Kunis, G., Koronyo‐Hamaoui, M., & Schwartz, M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05652.x · Cited by 167
CXC chemokines generate age-related increases in neutrophil-mediated brain inflammation and blood–brain barrier breakdown
Anthony, D. C., Dempster, R., Fearn, S., Clements, J. M., Wells, G., Perry, V. H., & Walker, K. M. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00373-9 · Cited by 161
Exacerbation of Ischemic Brain Damage by Localized Striatal Injection of Interleukin-1β in the Rat
Stroemer, R. P., & Rothwell, N. J. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199808000-00003 · Cited by 159
Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with β-amyloid[25–35]
Meda, L., Baron, P., Prat, E., Scarpini, E. A., Scarlato, G., Cassatella, M. A., & Rossi, F. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00188-x · Cited by 157
Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes.
Tani, M., Fuentes, M. E., Peterson, J. W., Trapp, B. D., Durham, S. K., Loy, J. K., Bravo, R., Ransohoff, R. M., & Lira, S. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118821 · Cited by 153
Interleukin‐1‐induced neurotoxicity is mediated by glia and requires caspase activation and free radical release
Thornton, P., Pinteaux, E., Gibson, R. M., Allan, S. M., & Rothwell, N. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03872.x · Cited by 152
Time-dependent reduction in Aβ levels after intracranial LPS administration in APP transgenic mice
Herber, D. L., Roth, L. M., Wilson, D. H., Wilson, N., Mason, J. E., Morgan, D., & Gordon, M. N. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.07.007 · Cited by 151
Glial Cytokines as Neuropathogenic Factors in HIV Infection
Stanley, L. C., Mrak, R. E., Woody, R. C., Perrot, L. J., Zhang, S., Marshak, D. R., Nelson, S. J., & Griffin, W. S. T. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199405000-00003 · Cited by 150
Self-citation
Chemokine-Dependent Neutrophil Recruitment in a Murine Model of Legionella Pneumonia: Potential Role of Neutrophils as Immunoregulatory Cells
Tateda, K., Moore, T. A., Newstead, M. W., Tsai, W. C., Zeng, X., Deng, J. C., Chen, G., Reddy, R. C., Yamaguchi, K., & Standiford, T. J. (2001) · Infection and Immunity · doi:10.1128/iai.69.4.2017-2024.2001 · Cited by 150
Interleukin-1 Promotes Expression and Phosphorylation of Neurofilament and tau Proteins in Vivo
Sheng, J. G., Zhu, S., Jones, R. A., Griffin, W. S. T., & Mrak, R. E. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7393 · Cited by 147
Self-citation
Long-Term Efficacy and Safety of Celecoxib in Alzheimer’s Disease
Soininen, H. S., West, C. R., Robbins, J. L., & Niculescu, L. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000096588 · Cited by 144
Interleukin-1 Influences Ischemic Brain Damage in the Mouse Independently of the Interleukin-1 Type I Receptor
Touzani, O., Boutin, H., Feuvre, R. A. L., Parker, L. C., Miller, A. J., Luheshi, G. N., & Rothwell, N. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00038.2002 · Cited by 141
Endogenous Interleukin-1 Receptor Antagonist is Neuroprotective
Loddick, S. A., Wong, M., Bongiorno, P. B., Gold, P. W., Licinio, J., & Rothwell, N. J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6436 · Cited by 140
Interleukin‐1 in the Brain: Mechanisms of Action in Acute Neurodegeneration
PATEL, H. C., BOUTIN, H., & ALLAN, S. M. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03136.x · Cited by 139
Induction of interleukin-1β mRNA in adult rat brain
Higgins, G. A., & Olschowka, J. A. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90139-o · Cited by 135
Expression of inducible nitric oxide synthase, interleukin-1 and caspase-1 in HIV-1 encephalitis
Zhao, M., Kim, M.-O., Morgello, S., & Lee, S. C. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00463-x · Cited by 134
Immunohistochemical localization of interleukin-1β, interleukin-1 receptor antagonist and interleukin-1β converting enzyme/caspase-1 in the rat brain after peripheral administration of kainic acid
Eriksson, C., van Dam, A., Lucassen, P. J., Bol, J. G. J. M., Winblad, B. G., & Schultzberg, M. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00178-5 · Cited by 132
Role of IL-1 and TNF in the brain: Twenty years of progress on a Dr. Jekyll/Mr. Hyde duality of the innate immune system
Gosselin, D., & Rivest, S. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.12.004 · Cited by 130
Neurotoxic effects of polymorphonuclear granulocytes on hippocampal primary cultures
Dinkel, K., Dhabhar, F. S., & Sapolsky, R. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0303510101 · Cited by 123
Interleukin-1 Receptor Antagonist Penetrates Human Brain at Experimentally Therapeutic Concentrations
Clark, S., McMahon, C. J., Gueorguieva, I., Rowland, M., Scarth, S., Georgiou, R. F., Tyrrell, P. J., Hopkins, S. J., & Rothwell, N. J. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600537 · Cited by 123
Neuroinflammation‐induced acceleration of amyloid deposition in the APPV717F transgenic mouse
Qiao, X., Cummins, D. J., & Paul, S. M. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01666.x · Cited by 119
Regulation of β-amyloid precursor protein isoform mRNAs by transforming growth factor-β1 and interleukin-1β in astrocytes
Gray, C. W., & Patel, A. J. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90037-p · Cited by 117
Neuroprotective actions of endogenous interleukin‐1 receptor antagonist (IL‐1ra) are mediated by glia
Pinteaux, E., Rothwell, N. J., & Boutin, H. (2005) · Glia · doi:10.1002/glia.20308 · Cited by 117
Demonstration of interleukin-1β in Lewis rat brain during experimental allergic encephalomyelitis by immunocytochemistry at the light and ultrastructural level
Bauer, J., BERKENBOSCH, F., van Dam, A., & Dijkstra, C. D. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90053-2 · Cited by 117
Distribution of interleukin‐1‐immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer’s disease
Sheng, Griffin, Royston, & Mrak (1998) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1998.00122.x · Cited by 115
Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease
Simard, A. R., & Rivest, S. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001809 · Cited by 113
Trisomy 21 and the Brain
Mrak, R. E., & Griffin, W. S. T. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.7.679 · Cited by 111
Self-citation
Learning modulation by endogenous hippocampal IL‐1: Blockade of endogenous IL‐1 facilitates memory formation
Depino, A. M., Alonso, M., Ferrari, C. C., del Rey, A., Anthony, D. C., Besedovsky, H. O., Medina, J. H., & Pitossi, F. J. (2003) · Hippocampus · doi:10.1002/hipo.10164 · Cited by 109
Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease
Quinn, J. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00037-7 · Cited by 102
Intracerebroventricular but not intravenous interleukin-1β induces widespread vascular-mediated leukocyte infiltration and immune signal mRNA expression followed by brain-wide glial activation
Proescholdt, M. G., Chakravarty, S., Foster, J. A., Foti, S., Briley, E. M., & Herkenham, M. A. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00048-9 · Cited by 96
Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human β-amyloid
Craft, J. M., Watterson, D. M., Hirsch, E., & Van Eldik, L. J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-15 · Cited by 96
Human leukocyte antigens and cytokine expression in cerebral inflammatory demyelinative lesions of X-linked adrenoleukodystrophy and multiple sclerosis
McGuinness, M. C., Powers, J. M., Bias, W. B., Schmeckpeper, B. J., Segal, A. H., Gowda, V. C., Wesselingh, S. L., Berger, J., Griffin, D. E., & Smith, K. D. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00020-9 · Cited by 89
Actions of the Pro‐Inflammatory Cytokine Il‐1[beta] on Central Synaptic Transmission
O'Connor, J. J., & Coogan, A. N. (1999) · Experimental Physiology · doi:10.1111/j.1469-445x.1999.01892.x · Cited by 87
The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease
Everbroeck, B. V., Dewulf, E. M., Pals, P., Lübke, U., Martin, J., & Cras, P. P. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00236-6 · Cited by 85
Intra-parenchymal injection of tumor necrosis factor-? and interleukin 1-? produces dopamine neuron loss in the rat
Carvey, P. M., Chen, E.-Y., Lipton, J. W., Tong, C. W., Chang, Q. A., & Ling, Z. D. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0222-z · Cited by 83
Overexpression of the Neuritotrophic Cytokine S100β Precedes the Appearance of Neuritic β‐Amyloid Plaques in APPV717F Mice
Sheng, J. G., Mrak, R. E., Bales, K. R., Cordell, B., Paul, S. M., Jones, R. A., Woodward, S., Zhou, X. Q., McGinness, J. M., & Griffin, W. S. T. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740295.x · Cited by 82
Self-citation
Attenuation of Ischemic Inflammatory Response in Mouse Brain Using an Adenoviral Vector to Induce Overexpression of Interleukin-1 Receptor Antagonist
Yang, G., Liu, X.-H., Kadoya, C., Zhao, Y., Mao, Y. Q., Davidson, B. L., & Betz, A. L. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199808000-00004 · Cited by 79
CNS injury: the role of the cytokine IL-1
Gibson, R. M., Rothwell, N. J., & Feuvre, R. A. L. (2004) · The Veterinary Journal · doi:10.1016/j.tvjl.2003.10.016 · Cited by 78
The pervasiveness of interleukin-1 in Alzheimer pathogenesis: a role for specific polymorphisms in disease risk
Griffin, W. S. T. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00110-8 · Cited by 72
Self-citation
IL-1 type I receptor plays a key role in mediating the recruitment of leukocytes into the central nervous system
Ching, S., He, L., Lai, W., & Quan, N. (2004) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2004.06.001 · Cited by 70
Differential effects of interleukin-1β on neurotoxicity, cytokine induction and glial reaction in specific brain regions
Depino, A. M., Ferrari, C. C., Godoy, M. C. P., Tarelli, R., & Pitossi, F. J. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.07.009 · Cited by 66
Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury
Lin, H., Basu, A., Druckman, C., Cicchese, M., Krady, J. K., & Levison, S. W. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-15 · Cited by 61
Pharmacokinetic modelling of interleukin‐1 receptor antagonist in plasma and cerebrospinal fluid of patients following subarachnoid haemorrhage
Gueorguieva, I., Clark, S., McMahon, C. J., Scarth, S., Rothwell, N. J., Tyrrell, P. J., Hopkins, S. J., & Rowland, M. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03026.x · Cited by 59
Differential regulation of type I and type II interleukin‐1 receptors in focal brain inflammation
Docagne, F., Campbell, S. J., Bristow, A. F., Poole, S., Vigues, S., Guaza, C., Perry, V. H., & Anthony, D. C. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03965.x · Cited by 47
Interleukin‐1β, but not IL‐1α, mediates nerve growth factor secretion from rat astrocytes via type I IL‐1 receptor
Jurič, D. M., & Čarman‐Kržan, M. (2001) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(01)00044-2 · Cited by 46
Intraparenchymal administration of interleukin-1β induces cyclooxygenase-2-mediated expression of membrane- and cytosolic-associated prostaglandin E synthases in mouse brain
Moore, A. H., Olschowka, J. A., & O’Banion, M. K. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.11.001 · Cited by 31
Self-citation
Gene regulation by IL‐1β independent of IL‐1R1 in the mouse brain
André, R., Moggs, J. G., Kimber, I., Rothwell, N. J., & Pinteaux, E. (2005) · Glia · doi:10.1002/glia.20302 · Cited by 30
Expression of intercellular adhesion molecule 1 (ICAM-1) is reduced in permanent focal cerebral ischemic mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist
Yang, G., Mao, Y. Q., Zhou, L., Gong, C., Ge, H., & Betz, A. L. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00335-0 · Cited by 30
The role of chronic self-propagating glial responses in neurodegeneration: Implications for long-lived survivors of human immunodeficiency virus
Mrak, R. E., & Griffin, W. S. T. (1997) · Journal of NeuroVirology · doi:10.3109/13550289709029465 · Cited by 25
Self-citation
Molecular analysis of prion protein (PrP) and glial fibrillary acidic protein (GFAP) transcripts in experimental Creutzfeldt-Jakob disease in mice
Kordek, R., Liberski, P. P., Yanagihara, R. T., Isaacson, S., & Gajdusek, D. C. (1997) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-1997-1215 · Cited by 24
Long-Term Monitoring of Insulin-Like Growth Factor I in Adult Growth Hormone Deficiency: A Critical Appraisal
Gibney, J., & Johannsson, G. (2004) · Hormone Research in Paediatrics · doi:10.1159/000080761 · Cited by 23
Interleukin-1 receptor 1 knockout has no effect on amyloid deposition in Tg2576 mice and does not alter efficacy following Abeta immunotherapy.
Das, P., Smithson, L. A., Price, R. W., Holloway, V. M., Levites, Y., Chakrabarty, P., & Golde, T. E. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-17 · Cited by 16
Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease Progression: A Randomized Controlled Trial
Aisen, P. S., Schafer, K. A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K. L., Farlow, M. R., Jin, S., Thomas, R. G., Thal, L. J., et al. (2003) · JAMA · doi:10.1001/jama.289.21.2819 · Cited by 5

Sorted by citations

Immune modulation of learning, memory, neural plasticity and neurogenesis
Yirmiya, R., & Goshen, I. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.015 · Cited by 1,483
Inflammasome signalling in brain function and neurodegenerative disease
Heneka, M. T., McManus, R. M., & Latz, E. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0055-7 · Cited by 836
Evidence for a cytokine model of cognitive function
McAfoose, J., & Baune, B. T. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.10.005 · Cited by 760
The role of the anaphylatoxins in health and disease
Klos, A., Tenner, A. J., Johswich, K.-O., Ager, R. R., Reis, E. S., & Köhl, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.027 · Cited by 730
Nrf2–ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases
Buendía, I., Michalska, P., Navarro, E., Gameiro‐Ros, I., Egea, J., & Leon, R. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.003 · Cited by 698

See all 565

Authors: Shaftel, S. S., Griffin, W. S. T., & O'Banion, M. K.
Affiliations: University of Rochester Medicine (US)
University of Arkansas for Medical Sciences (US)
ORCID: Griffin, W Sue T
Venue: Journal of Neuroinflammation
Publisher: Springer Science and Business Media LLC
Published: 2008-02-26
Volume: 5
Issue: 1
Pages: 7-7
ISSN: 1742-2094 (ISSN-L)
DOI: 10.1186/1742-2094-5-7
PMC: PMC2335091
OpenAlex: W2015186493
Cited by: 565
References: 158
Citations by year: 2026: 22 · 2025: 49 · 2024: 47 · 2023: 55 · 2022: 36 · 2021: 43 · 2020: 42 · 2019: 34 · 2018: 23 · 2017: 28 · 2016: 21 · 2015: 30 · 2014: 27 · 2013: 32 · 2012: 25
FWCI: 1.46
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
Locations: Journal of Neuroinflammation (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders: National Institute of Neurological Disorders and Stroke (R21NS048522)
Topics: Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
Keywords: interleukin-1, neuroinflammation, Alzheimer's disease, inflammatory cytokines, acute brain injury, neurodegenerative diseases, leukocyte recruitment
MeSH terms: Alzheimer Disease, Animals, Central Nervous System, Encephalitis, Humans, Interleukin-1, Leukocytes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks